SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-269276
Filing Date
2018-09-07
Accepted
2018-09-07 17:10:00
Documents
10
Period of Report
2018-09-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d618110d8k.htm 8-K 27741
2 EX-1.1 d618110dex11.htm EX-1.1 93579
3 EX-1.2 d618110dex12.htm EX-1.2 62469
4 EX-4.1 d618110dex41.htm EX-4.1 444031
5 EX-4.2 d618110dex42.htm EX-4.2 310013
6 EX-5.1 d618110dex51.htm EX-5.1 18045
7 EX-99.1 d618110dex991.htm EX-99.1 10434
8 GRAPHIC g618110g40m60.jpg GRAPHIC 3209
9 GRAPHIC g618110g48i09.jpg GRAPHIC 3319
10 GRAPHIC g618110g59n13.jpg GRAPHIC 3222
  Complete submission text file 0001193125-18-269276.txt   981314
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 181060774
SIC: 2834 Pharmaceutical Preparations